docetaxel anhydrous has been researched along with Conjunctivitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalvatzis, N; Dimitrakos, S; Hytiroglou, P; Manthou, ME; Tzamalis, A | 1 |
| Doughman, DJ; Skolnick, CA | 1 |
| Esmaeli, B | 1 |
1 review(s) available for docetaxel anhydrous and Conjunctivitis
| Article | Year |
|---|---|
Management of excessive tearing as a side effect of docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Conjunctivitis; Constriction, Pathologic; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Taxoids | 2005 |
2 other study(ies) available for docetaxel anhydrous and Conjunctivitis
| Article | Year |
|---|---|
Erosive conjunctival and corneal inflammatory changes in a patient receiving weekly docetaxel for breast cancer.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Conjunctivitis; Diagnosis, Differential; Docetaxel; Drug Administration Schedule; Female; Humans; Keratitis; Taxoids | 2014 |
Erosive conjunctivitis and punctal stenosis secondary to docetaxel (taxotere).
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Conjunctivitis; Docetaxel; Female; Humans; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids | 2003 |